[go: up one dir, main page]

NO321411B1 - Anvendelse av kalpastatin for fremstilling av et preparat for behandling av cancer - Google Patents

Anvendelse av kalpastatin for fremstilling av et preparat for behandling av cancer Download PDF

Info

Publication number
NO321411B1
NO321411B1 NO19964772A NO964772A NO321411B1 NO 321411 B1 NO321411 B1 NO 321411B1 NO 19964772 A NO19964772 A NO 19964772A NO 964772 A NO964772 A NO 964772A NO 321411 B1 NO321411 B1 NO 321411B1
Authority
NO
Norway
Prior art keywords
calpastatin
proteins
nucleic acid
use according
wild
Prior art date
Application number
NO19964772A
Other languages
English (en)
Norwegian (no)
Other versions
NO964772L (no
NO964772D0 (no
Inventor
Jean-Marie Blanchard
Serge Carillo
Marc Peichaczyk
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO964772L publication Critical patent/NO964772L/no
Publication of NO964772D0 publication Critical patent/NO964772D0/no
Publication of NO321411B1 publication Critical patent/NO321411B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19964772A 1994-05-31 1996-11-11 Anvendelse av kalpastatin for fremstilling av et preparat for behandling av cancer NO321411B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9406583A FR2720277B1 (fr) 1994-05-31 1994-05-31 Méthode de traitement des cancers par régulation de la protéine P53.
PCT/FR1995/000670 WO1995033060A1 (fr) 1994-05-31 1995-05-22 Methode de traitement des cancers par regulation de la proteine p53

Publications (3)

Publication Number Publication Date
NO964772L NO964772L (no) 1996-11-11
NO964772D0 NO964772D0 (no) 1996-11-11
NO321411B1 true NO321411B1 (no) 2006-05-08

Family

ID=9463670

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964772A NO321411B1 (no) 1994-05-31 1996-11-11 Anvendelse av kalpastatin for fremstilling av et preparat for behandling av cancer

Country Status (8)

Country Link
EP (1) EP0763121A1 (sv)
JP (1) JPH10500978A (sv)
AU (1) AU714209B2 (sv)
CA (1) CA2190293C (sv)
FI (1) FI120501B (sv)
FR (1) FR2720277B1 (sv)
NO (1) NO321411B1 (sv)
WO (1) WO1995033060A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518488C1 (de) * 1995-05-19 1996-10-10 Progen Biotechnik Gmbh Autoantigen, geeignet zur Feststellung einer Thromboseneigung
EP0799892A3 (en) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, its production and use
US6232454B1 (en) 1998-02-27 2001-05-15 Incyte Genomics, Inc. Human proteinase molecules
AU2344100A (en) * 1998-11-18 2000-06-05 Canji, Inc. Viral vectors with late transgene expression
AU2001247922A1 (en) * 2000-03-31 2001-10-15 Parker Hughes Institute Calpain inhibitors in cancer treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753665B2 (ja) * 1984-04-20 1995-06-07 財団法人癌研究会 抗転移剤
US5340922B1 (en) * 1988-05-31 1999-11-02 Mclean Hospital Corp Neural calcium-activated neutral proteinase inhibitors
EP0395309B1 (en) * 1989-04-28 1995-12-27 Takara Shuzo Co. Ltd. Human calpastatin-like polypeptide
JPH0641067A (ja) * 1992-04-20 1994-02-15 Kitasato Inst:The 新規カルパイン阻害物質ｋｐ−１２４１及びその製造法
EP0580161A1 (en) * 1992-07-22 1994-01-26 THE McLEAN HOSPITAL CORPORATION Prophylactic and therapeutic treatment of Alzheimer's disease
US5607831A (en) * 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death

Also Published As

Publication number Publication date
FI120501B (sv) 2009-11-13
FI964783A0 (sv) 1996-11-29
FR2720277A1 (fr) 1995-12-01
EP0763121A1 (fr) 1997-03-19
CA2190293C (fr) 2011-06-28
AU714209B2 (en) 1999-12-23
WO1995033060A1 (fr) 1995-12-07
CA2190293A1 (fr) 1995-12-07
FI964783L (sv) 1996-11-29
JPH10500978A (ja) 1998-01-27
FR2720277B1 (fr) 1996-07-12
NO964772L (no) 1996-11-11
NO964772D0 (no) 1996-11-11
AU2620695A (en) 1995-12-21

Similar Documents

Publication Publication Date Title
US6143290A (en) Tumor regression by adenovirus expression of wild-type p53
NO321454B1 (no) Defektiv, rekombinant adenovirus inneholdende en heterolog DNA-sekvens hvis ekspresjon i en malcelle tillater i det minste partielt a inhibere celledeling, anvendelser og farmasoytisk preparat derav.
US20030060432A1 (en) Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
FR2766091A1 (fr) Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee
KR20000075924A (ko) 알파-페토단백질 발현 세포에 특이적인 아데노바이러스 벡터 및 그것의 사용방법
AU724324B2 (en) p16 expression constructs and their application in cancer therapy
NO322477B1 (no) P53 variant, nukleinsyre, ekspresjonskassett, vektor, farmasoytisk preparat samt anvendelse for fremstilling av et farmasoytisk preparat for behandling av hyperproliferative lidelse.
EP0719328B1 (fr) Gene grb3-3, ses variants et leurs utilisations
NO321411B1 (no) Anvendelse av kalpastatin for fremstilling av et preparat for behandling av cancer
JP4371178B2 (ja) 抗ｐ５３一本鎖抗体フラグメント及びその使用
Mabrouk et al. Two basic motifs of reovirus σ3 protein are involved in double-stranded RNA binding
AU730324B2 (en) Use of protein gax for treating cancer
Randrianarison et al. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21
US7837991B2 (en) Method of cancer treatment by p53 protein control
KR102566745B1 (ko) 암의 예방 또는 치료를 위한 Runx3 변이 단백질
CA3192417A1 (en) Enhancing immunity using chimeric cd40 ligand and coronavirus vaccine
US20220033450A1 (en) Virally expressed inhibitors of pdz domains, such as pick1 and uses thereof
MXPA96005522A (en) Method for the treatment of cancer through the control of protein
Bernloehr et al. Efficient propagation of single gene deleted recombinant Sendai virus vectors
US6849438B1 (en) Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1)
FR2734826A1 (fr) Deltap62, ses variants, sequences nucleiques et leurs utilisations
KR101607282B1 (ko) 유리형 산화환원조절단백-1 및 이를 함유하는 항염증 약학조성물
WO2015177330A1 (en) Methods and pharmaceutical compositions for the treatment of heart failure
Shatkin et al. Translation Regulation by Reovirus Structural Proteins
Chin Inhibition of TNF signal transduction by the adenovirus RID complex

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees